BioNexus Gene Lab Corp
BGLC$2.30▲ 0.66% 24h
BioNexus Gene Lab CorpBGLC$2.30
+$0.8744(+61.55%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$5.55M
P/E ratio
—
EPS (diluted)
$-0.09
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$7.42M
Net income
$-2.98M
Net margin
-40.2%
Gross margin
14.6%
Dividends & financials
BioNexus Gene Lab Corp (BGLC) reported revenue of $7.42M and net income of $-2.98M, or $-0.09 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.